1. Recurrent Translocations in Topoisomerase Inhibitor-Related Leukemia Are Determined by the Features of DNA Breaks Rather Than by the Proximity of the Translocating Genes
   Nikolai A. Lomov et al, 2022, International Journal of Molecular Sciences CrossRef
2. A case mimicking chronic myeloid leukemia with t(8;22)(p11;q11)/BCR-FGFR1 and sequential transformation to B-acute lymphoblastic leukemia and acute myeloid leukemia
   Ayse Gul Bayrak et al, 2021, Journal of Hematopathology CrossRef
3. Acute Promyelocytic Leukemia Masquerading as Sero-negative Polyarthritis: Case Report
   Priyanka Chauhan et al, 2022, Indian Journal of Medical and Paediatric Oncology CrossRef
4. Acute myeloid leukemia with a cryptic NUP98/PRRX2 rearrangement developing after low-dose methotrexate therapy for rheumatoid arthritis
   Kazuhisa Chonabayashi et al, 2019, Annals of Hematology CrossRef
5. Mechanisms of Secondary Leukemia Development Caused by Treatment with DNA Topoisomerase Inhibitors
   Nikolai A. Lomov et al, 2023, Biochemistry (Moscow) CrossRef
6. Cell models with inducible oncogenic translocations allow to evaluate the potential of drugs to favor secondary translocations
   Anna Shmakova et al, 2023, Cancer Communications CrossRef
7. H2AFY is a novel fusion partner of MECOM in acute myeloid leukemia
   Qiaoyan Han et al, 2018, Cancer Genetics CrossRef
8. Cancer chemotherapeutics in rheumatoid arthritis: A convoluted connection
   S. Jayashree et al, 2018, Biomedicine & Pharmacotherapy CrossRef
9. Mechanisms for the development of therapy-related leukaemia caused by topoisomerase inhibitors
   N. A Lomov et al, 2023, Биохимия CrossRef